The anaplastic large cell lymphoma (ALCL) is a type of leukaemia which occurs primarily in children and young adults. An international team of researchers with significant involvement of MedUni Wien has now been able to demonstrate that the transcription factor BATF3 and its target genes play a key role in the growth of the tumour […]
Read More… from New therapy approach anaplastic large cell lymphoma
SARS-CoV-2 not found in DNA sequencing: University of Queensland researchers are refuting claims that COVID-19 can enter a person’s DNA. The researchers from UQ’s Queensland Brain Institute say the claims have led to “scaremongering” and people should not hesitate to be vaccinated. Professor Geoff Faulkner said his team’s research published in Cell Reports showed there was no evidence of COVID-19 […]
Neurodegenerative disease genetic discovery: A ‘perfect storm’ of genetic mutations, toxic proteins and a defect in natural cell recycling has been uncovered in University of Queensland research that could lead to treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Researchers have found brain cells are particularly vulnerable to the impacts of the triple threat, […]
An ‘astounding’ find reveals a rare cause of epilepsy: Researchers at The University of Queensland, working to gain a better understanding of how brain cells work, have discovered the underlying mechanism of a rare genetic mutation that can cause epilepsy. Dr Victor Anggono from UQ’s Queensland Brain Institute said his team made the ground-breaking findings while researching nerve […]
AID/APOBECs among important factors in body’s defence against SARS-CoV-2: Together with their multifaceted action mechanisms, activation-induced cytidine deaminase (AID) and so-called APOBEC proteins are important factors in the body’s immune response and offer fast and effective protection against a large number of DNA and RNA viruses. The task of AID is to strengthen the human […]
MicroRNAs may contribute to atherogenesis in a cell-type-dependent manner: Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner. Published in the Arteriosclerosis, Thrombosis, and Vascular Biology journal, the study provides novel insight into the miRNA profiles of the main cell types involved in atherosclerosis. […]
Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in regulating the gene expression of vascular endothelial growth factors (VEGF), the master regulators of angiogenesis. The study, conducted by the research groups of Associate Professor Minna Kaikkonen-Määttä and Academy Professor Seppo Ylä-Herttuala, provides a better understanding of the complex […]
Read More… from Novel non-coding RNAs regulating blood vessel formation
Australian medical devices manufacturing facility first: The launch of Australia’s first medical device development and manufacturing facility in Melbourne is set to fast-track new treatments for people with conditions such as epilepsy, Parkinson’s disease, hearing loss, stroke and diabetes. The new facility called Neo-Bionica, a joint venture between the Bionics Institute and the University of […]
New factor in the development of psoriasis discovered: Psoriasis is a common inflammatory skin condition. The underlying genetic factors have not yet been sufficiently researched. The skin inflammation is usually triggered by external factors such as infections or stress. A research team at the Institute of Cancer Research of the Medical University of Vienna has […]
The new Master’s course in “Molecular Precision Medicine” is concerned with how diseases develop and how to treat them on a molecular and mechanistic level. The course, jointly organised by the Medical University of Vienna and University of Vienna, combines scientists from the fields of basic research as well as translational and clinical research and […]
Read More… from Master’s course in Molecular Precision Medicine